Tumour suppression associated with expression of human insulin-like growth factor II
1991

Tumour Suppression Linked to IGF-II Expression

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): P.N. Schofield, A. Lee, D.J. Hill, J.E. Cheetham, D. James, C. Stewart

Primary Institution: University of Oxford

Hypothesis

Does the expression of IGF-II act as a tumour suppressor in fibroblast cell lines?

Conclusion

The study suggests that IGF-II may function as a tumour suppressor gene, as its expression led to increased latency in tumour formation in mice.

Supporting Evidence

  • Cells expressing IGF-II showed a five-fold increase in latency of sarcoma formation in mice.
  • Most tumours derived from IGF-II expressing cells lost the introduced IGF-II genes.
  • IGF-II expression was associated with a significant reduction in tumour growth in vivo.

Takeaway

Researchers found that a protein called IGF-II can help stop tumours from growing in mice, even though it usually helps cells grow.

Methodology

The study involved infecting fibroblast cell lines with IGF-II cDNA and observing the effects on growth and tumour formation in nude mice.

Limitations

The study primarily used a specific cell line and may not fully represent other types of cells or tumours.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication